IRB Approval Signals ‘Green Light’ for Sernova’s Clinical Protocol to ProceedLONDON, Ontario, May 14, ...
RAMSEY, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage ...
Solid Performance from New Product Launches VabomereTM Granted NTAP Status by CMS Strengthened Financial Position ...
